Aurobindo Pharma Appoints RPR & Associates as Secretarial Auditor
Aurobindo Pharma Limited has accepted the resignation of M/s. MRR & Associates as Secretarial Auditor effective May 22, 2026, due to health issues. The board has appointed M/s. RPR & Associates as the new Secretarial Auditors for a term of five consecutive years from FY 2026-27 to FY 2030-31, pending shareholder approval.

*this image is generated using AI for illustrative purposes only.
Aurobindo Pharma Limited has announced a change in its secretarial auditor following a board meeting held on May 21, 2026. The company accepted the resignation of its existing auditor, M/s. MRR & Associates, effective from May 22, 2026. The resignation was attributed to health issues concerning the firm's sole proprietor.
Consequently, the board approved the appointment of M/s. RPR & Associates, Company Secretaries in Practice, as the new Secretarial Auditors. The appointment is for a term of five consecutive years, commencing from FY 2026-27 and extending to FY 2030-31. This decision is subject to the approval of shareholders at the ensuing Annual General Meeting.
Details of the Change
The transition involves the cessation of the previous firm and the onboarding of a new entity to ensure compliance with regulatory requirements. The board meeting, which commenced at 4:30 p.m. and concluded at 6:25 p.m., reviewed the necessary disclosures pursuant to Regulation 30 of the SEBI Listing Regulations.
Key Particulars of Appointment
| Particulars | Details |
|---|---|
| New Firm | M/s. RPR & Associates |
| Firm Registration No. | S2017TL469100 |
| Appointment Date | May 21, 2026 |
| Term | Five consecutive years (FY 2026-27 to FY 2030-31) |
| Resignation Effective Date | May 22, 2026 |
Profile of New Auditor
M/s. RPR & Associates is a peer-reviewed firm of company secretaries in practice. The firm specializes in delivering professional services across Corporate Laws, SEBI Regulations, and FEMA Regulations. Its expertise includes conducting Secretarial Audits, Due Diligence Audits, and Compliance Audits. The proprietor, Mr. Y. Ravi Prasada Reddy, has over 23 years of experience as a practicing Company Secretary.
Historical Stock Returns for Aurobindo Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.38% | -3.14% | +5.16% | +21.36% | +21.54% | +44.45% |
How might shareholders respond to the appointment of M/s. RPR & Associates at the upcoming Annual General Meeting, and are there any potential risks of the resolution not being approved?
Could the abrupt transition in secretarial auditors create any compliance gaps or delays in Aurobindo Pharma's regulatory filings with SEBI during the handover period?
Given M/s. RPR & Associates' specialization in FEMA Regulations, does this appointment signal that Aurobindo Pharma may be planning increased cross-border transactions or international expansion activities?


































